Navigation Links
SoundBite(TM) Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology & Neurotology Journal
Date:7/6/2009

d communication platform that relies on the principle of bone conduction to undetectably transmit sound via the teeth to the inner ear. Its SoundBite(TM) hearing system is designed to help people who are essentially deaf in one ear to regain spatial hearing ability and rejoin the conversation of life. It is currently for investigational use only.

Following a review of existing treatment approaches for SSD, Dr. Popelka noted that "Both objective and subjective measurements from our study indicate that the new sound delivery system offers important potential benefits for a non-surgical treatment of single sided deafness. Based on the positive results and patient-perceived improvements, additional studies to investigate overall effectiveness and spatial hearing of this device are clearly warranted."

About SoundBite(TM)

SoundBite(TM) hearing system is the world's first and only non-surgical and removable hearing solution that imperceptibly transmits sound via the teeth to help people who are essentially deaf in one ear to rejoin the conversation of life. A nearly invisible digital audio device, SoundBite(TM) relies on a well-established principle called bone conduction to deliver clear, high quality sound, and is intended to restore normal hearing functions to people with either single sided deafness, conductive, or mixed hearing loss. The SoundBite(TM) system consists of an easy to insert and remove dental retainer-like device which requires no modifications to your teeth, and a small microphone unit worn behind the ear. This device is for investigational use only and is currently slated for clinical trials that are intended to support an initial filing for FDA 510(k) clearance for single sided deafness.

About Sonitus Medical

Sonitus Medical Inc. is a privately held medical device company developing the SoundBite(TM) hearing system, a non-surgical and removable hearing solution that i
'/>"/>

SOURCE Sonitus Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cystic Fibrosis Treatment May Cause Hearing Loss
2. Siemens Hearing Instruments Introduces Affordable and Flexible Pure 300
3. AAHSA Statement on House Ways and Means Committee Hearing
4. Fathers' Hearing Affects Family Function and Fiscal Health
5. Online Store Offers Affordable Digital Hearing Aids For Baby Boomers
6. SETO Holdings, Inc. Completes Agreement to Acquire Advanced Hearing Centers, Inc. and Has Disposed of All Existing Business; New Management has been installed
7. Global network formed to improve hearing implant outcomes
8. Purple Communications(TM) Launches Dream Bigger Initiative Celebrating the Stories, Culture, and Heritage of Americas Deaf and Hard-of-Hearing Community
9. Consumer Reports: Hearing Aid Shoppers Pay High Prices, Get Mediocre Fittings
10. The Quigley Corporation Announces Final Voting Results for 2009 Annual Meeting of Shareholders; Judge Orders Incumbent Board to Remain In Place Until Further Hearing; Final Outcome of Director Election Remains Uncertain
11. Siemens Promotes May is Better Speech and Hearing Month on Americas Largest Stage

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,, KANSASCITY,Mo.,Nov.25/PRNewswire/--TheBartle...,slargestmedicalcliniconDec.9-10,whenKansasCityhos...edpeople. ,, "Thisfreecliniceventhasthepotentia...ysinsteadofjustoneandbeheldonweekdaysinsteadofover...tyFreeHealthClinicandpresidentoftheNationalAssocia...
(Date:11/25/2009)...,, SILVERSPRING,Md.,Nov.25/PRNewswire-USNewswir...,sCenterforDrugEvaluationandResearch,titled"ADiffi...ppearsintheNov.26,2009issueofTheNewEnglandJournalo...-bin/prnh/20090824/FDALOGO ) ,, Inthearticle,Wo...cesstopainmedicationforthosewhoneeditandmanagingth...
(Date:11/25/2009)...Researchers have found evidence of a statistically...fen among patients whose estrogen receptor (ER)-po...f ER-alpha; at serine-118 (ER-alpha S118-P), accor...ember 25 in the Journal of the National Cancer In...as are resistant to tamoxifen. Preclinical studies...
(Date:11/25/2009)... Evaluation and treatment c... Woodstock (Vocus) November 25, 2009 -- C...nasal vaccines and H1N1 vaccine shots at four Cent...another shipment of vaccine has arrived. The clini... Lake and McHenry and will be open as follows: , ...
(Date:11/25/2009)...,, ARLINGTON,Va.,Nov.25/PRNewswire-USNewswire/-...reventHealthCareFraudActof2009,"S.2128,whichisdesi...letopreventfraudinMedicare.ThebillwasintroducedbyS...ainsseveralprovisionstheAmericanAssociationforHome...htheAssociationproposedtoCongressinFebruary.Thosep...
Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2
...culture had found out a soluble ingredient which w...sorption of the fat at a healthier level. Another ...luble cellulose, reduces the probability of develo... as the one that adds texture. The use of this ing...
...ation (WHO) the apex medical body warns the people... avian influenza or bird flu virus in the area. I... to provide full information to WHO regarding new ... complete the ongoing assessment of the nature of ...
... by Teva Pharmaceutical Industries Ltd. is said to...disease. According to the latest investigatio... physical abilities of patients suffering from Par...ease the extent of motor activities for the patien...
...ription could be used to avoid medical mistakes, b...// may lead to even more errors. It is known th...0,000 people in hospitals each year. One way hospi...ms may actually be leading to more mistakes. Th...
...ther antihypertensive strategies that use calcium ...r to older treatments with beta-blockers and diure... calcium channel blocker amlodipine with or withou... was prematurely stopped after concerns arose that...
...the most common form of brain cancer might fare be...motherapy than radiotherapy alone . Based on fi...ith the type of cancer known as glioblastoma recei...as who were randomized to receive either radiother...
Other Medicine News:
(Date:11/25/2009)...NEY,Nov.25/PRNewswire-FirstCall/--HeartWareInterna...orandprovideroflessinvasive,miniaturizedcirculator...dvancedheartfailure,todayannouncedthatitisschedule...affrayHealthCareConferenceat8:00amESTonWednesday,D...PalaceHotel,December1-2. ,, AlivewebcastoftheCo...
(Date:11/24/2009)...wswire/-- ,, WHAT:RomHoubens,aBelgianmanthought...wasactuallyfullyconsciousandawakeduringthattimeand...oxEyeMaxwasfeaturedinthesegmenttoillustratehowpeop...communication. ,, WHEN:GoodMorningAmerica-- Tue...ch.com ,, WHO:RomHoubenswasanengineeringstu...
(Date:11/24/2009)...PRNewswire-FirstCall/--Vermillion,Inc.(VRML)(PinkS...anizationandDisclosureStatementtoday,November24,20...tofDelaware.AhearingtoconsiderapprovaloftheDisclos...withthehearingontheconfirmationofthePlanscheduledf...payallclaimsinfull.ThePlanisexpected,ifapproved,to...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Scientists pinpoint protein link to fat storage 9969 1Siemens Donation of Digital Radiography System Benefits Childrens Health Fund 57526 1Siemens Donation of Digital Radiography System Benefits Childrens Health Fund 57526 2Siemens Donation of Digital Radiography System Benefits Childrens Health Fund 57526 3Siemens Donation of Digital Radiography System Benefits Childrens Health Fund 57526 4Community Health Centers and Western Governors University Partner to Address RN Shortage 57522 1Community Health Centers and Western Governors University Partner to Address RN Shortage 57522 2Community Health Centers and Western Governors University Partner to Address RN Shortage 57522 3Community Health Centers and Western Governors University Partner to Address RN Shortage 57522 4
...ificantly Improved Key PSG Parameters of Sleep Mai...tudy Ongoing -, SAN DIEGO, June 12 Arena Pharmac...t Dr. Thomas Roth of Henry Ford,Hospital presented...l of,APD125 for the treatment of insomnia in an or...ing of the Associated Professional Sleep Societies...
...GAITHERSBURG, Md., June 12 ,Micromet, Inc. (Nasdaq...irst,patient has started treatment in a multi-cent...ng BiTE(R) antibody blinatumomab (MT103/MEDI-538) ...a (ALL). Blinatumomab is a T,cell engaging antibod...sed,on B cells. The clinical development program f...
Other Medicine Technology:Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 2Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 3Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 4Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 5Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 6Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 2Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 3Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 4Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 5Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 6
AST (SGOT) Reagent (Colorimetric, Endpoint Procedure)
AST-GOT
...-line worker" for routine staining protocols frequ...s. It automatically stains big quantities of slide...of reagent stations in combination with a continuo...p to 12 baskets with 30 slides each can be process...
MS/DS 50/100 Slide Stainer
Medicine Products: